These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16723311)

  • 1. Vaginal pH-lowering effect of locally applied vitamin C in subjects with high vaginal pH.
    Polatti F; Rampino M; Magnani P; Mascarucci P
    Gynecol Endocrinol; 2006 Apr; 22(4):230-4. PubMed ID: 16723311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study.
    Petersen EE; Magnani P
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):70-5. PubMed ID: 15474248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an acidic vaginal gel on vaginal pH and interleukin-6 levels in low-risk pregnant women: a double-blind, randomized placebo-controlled trial.
    Paternoster DM; Tudor L; Milani M; Maggino T; Ambrosini A
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):198-201. PubMed ID: 15280147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled clinical trial.
    Petersen EE; Genet M; Caserini M; Palmieri R
    Arzneimittelforschung; 2011; 61(4):260-5. PubMed ID: 21650086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
    Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Giguere JF; Domingo MC; Piret J; Tsague L; Zekeng L; Mwatha A; Mâsse B; Bergeron MG
    Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
    Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC
    AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study evaluating the safety of vaginal administration of a multi-particulate pellet formulation.
    Santiago GL; Verstraelen H; Poelvoorde N; De Corte S; Claeys G; Trog M; De Backer E; Saerens B; Vervaet C; De Boeck F; Van Bortel L; Remon JP; Temmerman M; Vaneechoutte M; Verhelst R
    Eur J Pharm Biopharm; 2009 Nov; 73(3):399-403. PubMed ID: 19733660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vaginal ascorbic acid on abnormal vaginal microflora.
    Zodzika J; Rezeberga D; Donders G; Vedmedovska N; Vasina O; Pundure I; Bite R; Silberga I; Socenova J; Melngaile O
    Arch Gynecol Obstet; 2013 Nov; 288(5):1039-44. PubMed ID: 23677418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Martel C; Balser J
    Gynecol Endocrinol; 2010 Jul; 26(7):524-32. PubMed ID: 20459349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
    Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
    Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of the local tolerance of vaginal formulations containing dapivirine using the Slug Mucosal Irritation test and the rabbit vaginal irritation test.
    Dhondt MM; Adriaens E; Roey JV; Remon JP
    Eur J Pharm Biopharm; 2005 Aug; 60(3):419-25. PubMed ID: 15996583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K; Kulp JL; Rosen M; Shera DM
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.